Fibroids are the
most common tumors in the female reproductive system. They
increase with age and as many as 50% of women at age 50 have
one or more fibroids. They are the most common cause for hysterectomy.
While fibroids are common in all races, studies have shown
that they are more common in African-Americans.
Uterine fibroids, also called myomas or leiomyomas, are a
benign tumor of the muscle of the uterus. Fibroids may range
from the size of a pea to that of a basketball. They may be
single or multiple.
Fibroids are usually described by the
position they occupy in the uterus. Some fibroids may be connected
to the uterus only by a thin stalk. These are called pedunculated
fibroids and are the least symptomatic of all types of
fibroids. If the fibroid is on the outside of the uterus,
it is called subserosal. Subserosal fibroids usually
cause fewer problems than those located deeper in the uterine
wall, which are called intramural. The last type
of fibroid, and perhaps the most significant for abnormal
bleeding and fertility, are the submucosal fibroids.
These fibroids lie just under the endometrium and have an
“iceberg” effect—more actually there than
is exposed at the surface.
A fibroid forms from a single muscle cell that begins to multiply.
The exact stimulus that causes this growth, or the stimulus
that limits fibroid growth, is not known. While the cells
of the fibroid multiply and the fibroid grows, it is very
different from a cancer in that the fibroid does not invade
surrounding tissues; it just pushes on them. Luckily, fibroids
are universally benign, although malignant transformation
is not impossible.
It is clear that fibroids are under the control of estrogen
and progesterone. After menopause, when the estrogen levels
fall, fibroids decrease in size. During pregnancy, fibroids
often increase in size. Some fibroids grow very quickly and
undergo death (degeneration) of the middle portions, thus
causing pain. Degeneration of fibroids is more common during
pregnancy.
Patients with fibroids most often are seen in their gynecologist’s
office with abnormal pain, abnormal uterine bleeding and enlargement
of the uterus. Back pain, frequent urination, and alteration
in bowel function are common symptoms. Often the fibroids
are suspected by pelvic examination and can be readily confirmed
by ultrasound scans. Sometimes they are discovered during
an infertility evaluation.
Usually an ultrasound scan is all that is necessary to make
the diagnosis. Most often fibroids have a characteristic finding
by ultrasound of what is called the homogeneous echo of the
“ball of muscle cells” surrounded by a capsule.
While most fibroids have a uniform appearance, some older
fibroids will have bright ultrasound shadows, suggesting calcification.
This is a normal and benign finding. A problem that may initially
look similar to a fibroid on ultrasound is an adenomyoma,
which is an area of endometriosis within the muscle of the
uterus. If the fibroid is near the uterine lining (submucosal)
it may be difficult to distinguish from an endometrial polyp,
but both of these are treated in the same way as fibroids.
“Big” is always a relative term colored by the
degree of discomfort caused and fears of both the patient
and physician. When it is agreed that a fibroid is large and
it has become unmanageable in other ways, it’s time
for surgery. If pregnancy is not desired this may mean a hysterectomy.
Most who have had hysterectomies because of fibroids are much
improved. Bleeding is gone and other symptoms at least improved.
The decision for hysterectomy is based on the size of the
fibroid, how fast it is growing, the amount of problems it
is causing and the desire for future pregnancy.
Unfortunately, there have been only a few studies that have
specifically addressed the role of fibroids in fertility.
Most believe that the fibroid must be above 3 cm. in size
to have a deleterious effect on fertility. Obviously, the
position of the fibroid may be more important than its size.
If it is found by evaluation using hysteroscopy, hysterosalpinography,
or sono-hystersalpinography that the fibroid is not impinging
on the uterine cavity, therapy may not be necessary. Large
fibroids, however, can further enlarge and cause pain in early
pregnancy, possibly altering the implantation site and causing
early or obstructed labor. A fibroid in the wall of the uterus
may prevent the uterus from properly expanding in pregnancy,
or stimulate premature contractions.
There is probably adequate justification for removing all
fibroids greater than 6 cm. regardless of their position.
Submucosal fibroids are usually removed by hysteroscopy. Intramural
and subserosal fibroids are removed by a procedure called
myomectomy, which can be performed either through an abdominal
incision (laparotomy) or by “band aid surgery”
(laparoscopy.) Some surgeons believe that any fibroid which
is sufficiently easy to remove at laparoscopy may be insignificant
in its capacity to effect fertility. Certainly, the laparoscopic
procedure has a much shorter recovery time, but the decision
for laparoscopic removal should be carefully considered. There
are recent studies advocating a destruction of the fibroid
by an electric current without actually removing the fibroid.
This procedure is questionable when a pregnancy is desired.
It is not known whether this technique will abnormally weaken
the wall of the uterus.
Once the fibroid is removed, the surrounding muscle is usually
closed with sutures. Inside the body, the area where the fibroid
has been removed forms a scar. This scar may not expand as
well as the muscle during pregnancy and can result in a uterine
rupture. Every patient who has had a fibroid removed should
also be informed as to whether cesarean section should be
performed to delivery subsequently conceived babies. Certainly,
the obstetrician should be made aware of a previous myomectomy.
Since fibroids are under the control of ovarian hormones,
agents that suppress ovarian functions such as the GnRH analogs
will also cause suppression of fibroids. Unfortunately, even
though the suppression may reduce the fibroid size by 50%,
the fibroid will quickly return when the suppressive therapy
has been stopped. Sometimes pretreatment with GnRH analogs
will control bleeding and will allow surgery to be carried
out with less blood loss and in some cases this will allow
an easier procedure. Pretreatment with GnRH analogs is especially
important with hysteroscopic removal of larger fibroids. Unfortunately,
suppressive therapy that lessens bleeding also increases scarring
around the fibroid, thus making the removal more difficult.
The effect of oral contraceptives and progestins such as Provera™
on fibroid growth is unclear. Overall, it is believed that
women who use birth control pills have a lower incidence of
fibroid changes.
A procedure for treating fibroids that is gaining acceptance
is uterine artery embolism. In this procedure, under X-ray
guidance the main blood supply to the fibroid is disrupted,
causing it to shrink. It is unclear whether this technique
can be safely used for those desiring a future pregnancy.
Early studies have shown embolization may be associated with
less favorable pregnancy outcome. It may weaken the uterine
wall, or more importantly, it may alter the necessary blood
supply to the uterus that is needed for normal placental function.
At the same time this procedure avoids a surgical scar in
the uterus, and mays lessen the chance of uterine rupture.
BACK
HOME |